Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model

Código QR

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model

Qingyou Chen,1 Yue Yin,2 Li Li,1 Yanjiao Zhang,1 Wei He,1 Yan Shi3 1Department of Neurology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar City, Heilongjiang Province, 161000, People’s Republic of China; 2Department of Science and Education, The Third Affiliated Hospital of Qi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen Q, Yin Y, Li L, Zhang Y, He W, Shi Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	milrinone alzheimer’s disease neuroinflammation memory loss cognitive deficit Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/5496b57c0810430996b1d462216546fe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-term icariin treatment ameliorates cognitive deficits via CD4+ T cell-mediated immuno-inflammatory responses in APP/PS1 mice
por: Zhu T, et al.
Publicado: (2019)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli MR, et al.
Publicado: (2016)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice
por: Kong L, et al.
Publicado: (2020)

Histone Deacetylase 2 Knockdown Ameliorates Morphological Abnormalities of Dendritic Branches and Spines to Improve Synaptic Plasticity in an APP/PS1 Transgenic Mouse Model
por: Daiki Nakatsuka, et al.
Publicado: (2021)

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
por: Fulop T, et al.
Publicado: (2021)

Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer’s disease in Hong Kong: a pilot study
por: Lee GY, et al.
Publicado: (2013)

Perfiles diagnósticos y epidemiológicos en una Unidad de Memoria
por: González H,Jorge, et al.
Publicado: (2005)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Guimei Zhang, et al.
Publicado: (2021)

Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice
por: Long-Long Cao, et al.
Publicado: (2021)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease
por: Choe YM, et al.
Publicado: (2018)

Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease
por: Avijit Banik, et al.
Publicado: (2021)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Wenjuan Rui, et al.
Publicado: (2021)

Electroacupuncture ameliorate learning and memory by improving N -acetylaspartate and glutamate metabolism in APP/PS1 mice
por: Lin,Ruhui, et al.
Publicado: (2018)

Activation of Adenosine Monophosphate-Activated Protein Kinase Drives the Aerobic Glycolysis in Hippocampus for Delaying Cognitive Decline Following Electroacupuncture Treatment in APP/PS1 Mice
por: Jianhong Li, et al.
Publicado: (2021)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
por: Kose Ozlece H, et al.
Publicado: (2018)

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: María Jesús Friedli, et al.
Publicado: (2021)

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study
por: Fujimoto H, et al.
Publicado: (2017)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice
por: Guohua Li, et al.
Publicado: (2021)

Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer’s Disease
por: Le Xu, et al.
Publicado: (2021)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Qinqin Wang, et al.
Publicado: (2021)

AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway
por: Xiaojin Sun, et al.
Publicado: (2021)

Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain
por: Xiangpei Yue, et al.
Publicado: (2021)

Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties
por: Aisha Siddiqui, et al.
Publicado: (2021)

Role of berberine in Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2016)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Investigating Markers of the NLRP3 Inflammasome Pathway in Alzheimer’s Disease: A Human Post-Mortem Study
por: Hao Tang, et al.
Publicado: (2021)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

TLR-Mediated Signal Transduction and Neurodegenerative Disorders
por: Shashank Vishwanath Adhikarla, et al.
Publicado: (2021)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Editorial: Targeting Neuroinflammation in Central Nervous System Disorders: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
por: Mariela Fernanda Pérez, et al.
Publicado: (2021)

Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation
por: Qin C, et al.
Publicado: (2021)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

What are the links between hypoxia and Alzheimer’s disease?
por: Lall R, et al.
Publicado: (2019)

Alzheimer's research & therapy
Publicado: (2009)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)